BriaCell Therapeutics Cor... (BCTX)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

0.66

-0.87%

Pre-market Dec 16, 2024, 04:33 AM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	82.58K	15.53K	15.14K	15.57K	13.99K	14.27K	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-82.58K	-15.53K	-15.14K	-15.57K	-13.99K	-14.27K	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-32.81M	-23.27M	-15.29M	3.69M	1.38M	946.42K	-3.82M	-2.58M	-1.67M	-1.44M	-437.27K	-424.26K	-1.20M	-1.05M	-324.57K	-233.87K	-114.12K	-129.06K	-8.58K
Interest Income	-	891.21K	136.73K	3.15K	39.48	9.13K	12.27K	5.16K	3.63K	7.09K	12.00K	16.90K	38.01K	13.36K	2.90K	2.73K	-	-	-
Pretax Income	-4.79M	-20.30M	-11.55M	3.69M	1.38M	946.42K	1.07M	-2.58M	-1.70M	-2.68M	-8.15M	-368.69K	-995.72K	-1.09M	-919.91K	-231.36K	-	-	-
Net Income	-4.79M	-20.30M	-11.58M	-2.89M	1.38M	602.68K	1.07M	-2.58M	-1.70M	-2.68M	-8.15M	-368.69K	-995.72K	-1.08M	-900.74K	-228.81K	-98.93K	-116.41K	-8.58K
Selling & General & Admin	5.97M	7.94M	7.27M	-3.67M	-1.37M	-932.17K	-1.05M	876.16K	942.02K	1.33M	436.17K	423.86K	556.06K	1.05M	323.27K	203.86K	114.12K	129.06K	8.58K
Research & Development	26.75M	15.34M	8.02M	1.32M	2.22M	3.74M	2.39M	1.71M	723.43K	105.82K	-	-	-	-	-	-	-	-	-
Other Expenses	-	-	-15.29M	-1.33M	-2.24M	-3.75M	-312.92K	290.00	1.79K	565.00	1.21K	404.00	-4.23K	2.40K	1.33K	2.33K	-	-	-
Operating Expenses	32.73M	23.27M	-3.39K	-3.69M	-1.38M	-946.42K	-1.07M	2.58M	1.67M	1.44M	437.27K	424.26K	551.84K	1.05M	324.57K	233.87K	114.12K	129.06K	8.58K
Interest Expense	-	-	979.00	46.09K	27.00K	23.82K	15.63K	-	-	-	-	-	-	-	-	-	-	-	-
Selling & Marketing Expenses	-178.93K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	32.81M	23.27M	-3.39K	-3.69M	-1.38M	-946.42K	-1.07M	2.58M	1.67M	1.44M	437.27K	424.26K	551.84K	1.05M	324.57K	233.87K	114.12K	129.06K	8.58K
Income Tax	62.85K	-152.62K	30.73K	6.58M	-72.25K	343.74K	1.59M	638.59K	547.97K	2.05M	8.45M	-44.35K	-200.92K	-24.03K	601.48K	12.46K	-12.72K	-5.10K	1.13K
Shares Outstanding (Basic)	16.45M	15.62M	15.49M	4.52M	713.89K	579.66K	427.81K	339.71K	288.44K	249.18K	59.00K	59.00K	58.83K	32.67K	18.17K	8.93K	4.84K	4.17K	2.05K
Shares Outstanding (Diluted)	16.45M	15.62M	15.49M	4.52M	713.89K	579.66K	427.81K	352.98K	288.44K	249.18K	59.00K	59.00K	58.83K	32.67K	18.17K	8.93K	4.84K	4.17K	2.05K
EPS (Basic)	-0.29	-1.3	-0.75	-0.64	1.94	1.04	2.49	-7.61	-5.88	-10.76	-138.07	-6.25	-16.93	-33.02	-49.58	-25.62	-20.45	-27.92	-4.18
EPS (Diluted)	-0.29	-1.3	-0.75	-0.64	1.94	1.04	2.49	-7.32	-5.88	-10.76	-138.07	-6.25	-16.93	-33.02	-49.58	-25.62	-20.45	-27.92	-4.18
EBITDA	-4.77M	-30.67M	-15.13M	-8.69M	-3.97M	-6.67M	-4.96M	-3.22M	-2.18M	-1.80M	-2.61K	-462.53K	-68.23K	-1.01M	255.79K	-233.72K	-114.12K	-129.06K	-8.58K
Depreciation & Amortization	82.58K	15.27K	15.27K	15.26K	15.26K	14.25K	12.97K	232.68	907.21	434.31	1.11K	392.08	1.72K	2.51K	1.29K	154.20	12.72K	5.10K	-1.13K